Proven Melanoma Patient Recruitment Results
Our specialized melanoma recruitment platform delivers faster enrollment across all stages and molecular subtypes.
Comprehensive Melanoma Patient Recruitment
Expert recruitment across all melanoma stages and molecular subtypes for accelerated clinical trial enrollment.
BRAF-Mutant Melanoma
Specialized recruitment for BRAF V600E/K mutant melanoma patients for targeted therapy trials
Advanced/Metastatic Melanoma
Stage III/IV melanoma recruitment for immunotherapy and combination treatment studies
Resectable Melanoma
Early-stage melanoma recruitment for adjuvant immunotherapy and targeted therapy trials
Mucosal Melanoma
Rare melanoma subtype recruitment for specialized treatment and combination therapies
Uveal Melanoma
Ocular melanoma patient recruitment for liver-directed therapies and systemic treatments
Cutaneous Melanoma
Standard cutaneous melanoma recruitment across all stages and treatment lines
Advanced Melanoma Recruitment Strategies
Multi-channel approach combining digital outreach, dermatology networks, and patient advocacy partnerships.
Digital Patient Outreach
Targeted campaigns reaching melanoma patients through social media, search marketing, and patient portals
Dermatology Network Partnerships
Direct relationships with dermatologists, surgical oncologists, and melanoma specialists
Patient Advocacy Collaboration
Partnerships with melanoma foundations, support groups, and skin cancer organizations
Molecular Testing Coordination
BRAF, NRAS, c-KIT mutation testing and PD-L1 expression analysis for precision recruitment